Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GPR40 Agonists. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step synthesis route from 1-fluorocyclopropanecarboxylic acid. Achieves >60% total yield, avoids fluoromethylation byproducts. Ideal for GPR40 agonist intermediates.